Recipharm Pharmaservices Private Limited, a active private limited company, was established on 30 December 2015 in Mumbai, Maharashtra, India. Engaging in chemical products within the manufacturing sector, it holds CIN: U24230MH2015PTC440983. Registered under ROC Roc Mumbai. it is unlisted. It has an authorized capital of ₹610.00 Cr and a paid-up capital of ₹418.70 Cr.
Formerly known as Dagny Pharma Private Limited. It upholds a compliant status. Employing 1,077 professional, Its leadership includes Suresh Nagappa Ganachari (Whole-Time Director), Ina Quinn (Director), Srinivas Rao Davuluri (Managing Director). Past directors included Anurag Bagaria, Karan Bagaria, Thomas Bengt Eldered. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at Flat No. 502, B Wing, Building 48, Tilak Indrayani Housing Society, Nagar (W), Chembur, India, Mumbai, Maharashtra, 400089.
U24230MH2015PTC440983
084997
30 December 2015
₹610.00 Cr
₹418.70 Cr
Roc Mumbai
Unlisted
Active
Explore comprehensive insights into Recipharm Pharmaservices Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Suresh Nagappa Ganachari | Whole-Time Director | 28 Nov 2022 | Current |
| Ina Quinn | Director | 05 Jan 2023 | Current |
| Srinivas Rao Davuluri | Managing Director | 08 Dec 2023 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | - | Past |
| Pramod Abcsdd | Director | - | Past |
| Pramod Abcsdd | Director | 26 Mar 2021 | Past |
| Pramod Abcsdd | Director | 11 Nov 2022 | Past |
| Pramod Abcsdd | Director | 15 Mar 2022 | Past |
| Pramod Abcsdd | Director | 31 Dec 2021 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Recipharm Pharmaservices Private Limited, for the financial year ended 2024, experienced significant growth in revenue, with a 32.67% increase. The company also saw a substantial improvement in profitability, with a 116.69% increase in profit. The company's net worth Soared by an impressive increase of 12.82%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2024, Recipharm Pharmaservices had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
There are no open charges registered against the company as per our records.
Recipharm Pharmaservices has a workforce of 1077 employees as of Mar 21, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Recipharm Pharmaservices, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Recipharm Pharmaservices's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Progress on Recipharm Pharmaservices Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was documented.
Progress on Suresh Nagappa Ganachari was appointed as a Company Secretary was appointed as a Company Secretary on 14 Aug 2024 & has been associated with this company since 10 months 11 days . was documented.
The activity Recipharm Pharmaservices Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Mumbai. was completed.
Progress on Srinivas Rao Davuluri was appointed as a Managing Director was appointed as a Managing Director on 08 Dec 2023 & has been associated with this company since 1 year 6 months . was documented.
The activity Ina Quinn was appointed as a Director was appointed as a Director on 05 Jan 2023 & has been associated with this company since 2 years 5 months . was completed.
Suresh Nagappa Ganachari was appointed as a Whole-Time Director was appointed as a Whole-Time Director on 28 Nov 2022 & has been associated with this company since 2 years 6 months . was recorded as a recent event.
When you finally get the last piece of the puzzle. #AcquisitionGoals #Recipharm #NitinLifesciences #SobtiFamily #BossMoves.
The CIN of Recipharm Pharmaservices Private Limited is U24230MH2015PTC440983.
Recipharm Pharmaservices Private Limited is headquartered at Flat No. 502, B Wing, Building 48, Tilak Indrayani Housing Society, Nagar (W), Chembur, India, Mumbai, Maharashtra, 400089.
Recipharm Pharmaservices Private Limited was incorporated on 30 December 2015.
The current directors of Recipharm Pharmaservices Private Limited are
The primary industry of Recipharm Pharmaservices Private Limited is Manufacturing.
Recipharm Pharmaservices Private Limited is unlisted.
The authorized capital of Recipharm Pharmaservices Private Limited is ₹610.00 Cr, and the paid-up capital is ₹418.70 Cr.
The compliance status of Recipharm Pharmaservices Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX